Kentaro Endo
Yushima, 1138510, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Piperlongumine attenuates knee osteoarthritis progression by eliminating senescent meniscus cells and chondrocytes.
Journal: Biochemical and biophysical research communications
Published: March 26, 2026
Autofluorescence and cell size-based sorting eliminates senescent cells in synovial mesenchymal stem cells from patients with osteoarthritis.
Journal: Tissue & cell
Published: January 14, 2026
Reciprocal Regulation of GLI1 and GLI3 Fine Tunes the Pathogenic Behavior of Synovial Fibroblasts in Rheumatoid Arthritis.
Journal: International journal of rheumatic diseases
Published: December 18, 2025
Effects of local anesthetics on yield and differentiation of synovial mesenchymal stem cells.
Journal: Scientific reports
Published: September 15, 2025
Early morphological and gene/protein expression dynamics of human synovial mesenchymal stem cells during adhesion to a damaged meniscal surface.
Journal: Scientific reports
Published: September 01, 2025
Enhanced lubricin secretion by human synovial mesenchymal stem cells compared to adipose mesenchymal stem cells.
Journal: Stem cell research & therapy
Published: January 27, 2025
Femoral cartilage defects initiate from medial meniscus extrusion or tibial cartilage lesions and expand in knee osteoarthritis as revealed by 3D MRI analysis.
Journal: Scientific reports
Published: July 19, 2024
Synovial mesenchymal stem cells secrete more lubricin than adipose mesenchymal stem cells after injection into rat osteoarthritis knees.
Journal: Biochemical and biophysical research communications
Published: July 03, 2024
Macrophage depletion in inflamed rat knees prevents the activation of synovial mesenchymal stem cells by weakening Nampt and Spp1 signaling.
Journal: Inflammation and regeneration
Published: June 12, 2024
Cellular senescence contributes to spontaneous repair of the rat meniscus.
Journal: Aging cell
Published: June 11, 2024
ARID5B is a negative modulator of IL-6 production in rheumatoid arthritis synovial fibroblasts.
Journal: Immunological medicine
Published: May 15, 2024
Last Updated: 09/26/2026